Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹1 LAccepted-AOC NA | NA | NA | 121004 | ₹1 L | L1 | Accepted-AOC DETAILS IN NOTICE |
| 2 | L1₹1 LAccepted-AOC | ₹1 L | L1 | Accepted-AOC DETAILS IN NOTICE |
| 3 | L1₹1 LAccepted-AOC 7 1 27 AMEERPET HYDERABAD TELANGANA INDIA 500016 | HYDERABAD | HYDERABAD | TELANGANA | 500016 | ₹1 L | L1 | Accepted-AOC DETAILS IN NOTICE |
| 4 | L1₹1 LAccepted-AOC | ₹1 L | L1 | Accepted-AOC DETAILS IN NOTICE |
| 5 | L1₹1 LAccepted-AOC | ₹1 L | L1 | Accepted-AOC DETAILS IN NOTICE |
| Sl No | Description | Qty | Unit | Fresenius Kabi Oncology Limited L3 | Emcure Pharmaceuticals Ltd L4 | Dr.Reddys LAboratories Limited L5 | BRUCK PHARMA PVT LTD L1 | Beta Drugs Limited L2 |
|---|---|---|---|---|---|---|---|---|
| 1.00 | CARFILZOMIB INJ 30 mg | 996 | Vial | - | - | 16,327 ₹1,959.24 | - | - |
| 2.00 | ERIBULIN INJ 0.44 mg/ml | 325 | 2 ml Vial | - | 6,500 ₹780 | - | - | - |
| 3.00 | LAPATINIB TAB IP 250 mg | 37,731 | 1 No | - | - | - | 49 ₹2.45 | 51 ₹2.55 |
| 4.00 | OCTREOTIDE INJ 30 mg | 386 | PFS | - | - | - | - | - |
| 5.00 | OCTREOTIDE INJ 20 mg | 88 | PFS | - | - | - | - | - |
| 6.00 | PACLITAXEL NANOPARTICLE INJ 100 mg | 1,719 | Vial | 3,858 ₹462.96 | - | - | - | - |
| 7.00 | PROTEIN BOUND PACLITAXEL INJ 100 mg | 4,344 | Vial | - | - | - | - | 1,338 ₹160.56 |
Tender Value
Refer Docs
EMD Value
₹50,000
Closing Date
30 Jul 2025, 5:00 pmClosed
Managing Director
KMSCL, THYCAUD
Re-tender for the procurement of Anti cancer drugs for the year 2025-26
2025_KMSCL_777250_1
KMSCL/ED/ACD/RT/2025/021
Open Tender
Medicines
365 days
Thiruvananthapuram
please refer tender document
22 documents required · 22 mandatory
₹9,600
Yes
₹50,000
Yes
online platform
5 Jun 2026
16 Jul 2025
1 Aug 2025
16 Jul 2025
30 Jul 2025
16 Jul 2025
16 Jul 2025 - 30 Jul 2025
21 Jul 2025
CARFILZOMIB INJ 30 mg
ERIBULIN INJ 0.44 mg/ml
LAPATINIB TAB IP 250 mg
OCTREOTIDE INJ 30 mg
OCTREOTIDE INJ 20 mg
PACLITAXEL NANOPARTICLE INJ 100 mg
PROTEIN BOUND PACLITAXEL INJ 100 mg
Beta Drugs Limited (BID ID -2262224)
Fresenius Kabi Oncology Limited (BID ID -2253519)
Emcure Pharmaceuticals Ltd (BID ID -2265091)
Dr.Reddys LAboratories Limited (BID ID -2266446)
stage.html
html • 0.06 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Download all tender documents and submit your bid